| pubmed-article:8094629 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8094629 | lifeskim:mentions | umls-concept:C0036341 | lld:lifeskim |
| pubmed-article:8094629 | lifeskim:mentions | umls-concept:C0017337 | lld:lifeskim |
| pubmed-article:8094629 | lifeskim:mentions | umls-concept:C0032706 | lld:lifeskim |
| pubmed-article:8094629 | lifeskim:mentions | umls-concept:C0042333 | lld:lifeskim |
| pubmed-article:8094629 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
| pubmed-article:8094629 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:8094629 | pubmed:dateCreated | 1993-3-24 | lld:pubmed |
| pubmed-article:8094629 | pubmed:abstractText | There is growing evidence that some genetic predisposition is important in the etiology of schizophrenia. We have sought to implicate a major gene by performing a candidate gene association study comparing the allele frequencies of seven restriction fragment length polymorphisms (RFLPs) at six loci in both a psychiatrically normal control group (N = 51) and an affected (schizophrenia or schizoaffective disorder) group (N = 55). Each group comprised Caucasians of northern European origin. The candidate areas (D5S39, D5S78, dopamine receptor D2 (DRD2), D11S29, porphobilinogen deaminase (PBGD), and D11S84) were selected on the basis of prior cytogenetic findings in schizophrenics, linkage studies, and/or implicated gene products. The presence of a polymorphic ApaLI site within the PBGD gene showed a significant association with the presence of illness (P = 0.02). The relative risk of possessing the allele with the ApaLI site was 2.10. No significant association was found with any of the six other RFLPs. Our data suggests that either the PBGD gene itself or an unknown gene linked to and/or in linkage disequilibrium with the PBGD locus predisposes some individuals to schizophrenia. Independent replication of these findings will be required to determine their relevance to schizophrenia. | lld:pubmed |
| pubmed-article:8094629 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8094629 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8094629 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8094629 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8094629 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8094629 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8094629 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8094629 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:8094629 | pubmed:issn | 0920-9964 | lld:pubmed |
| pubmed-article:8094629 | pubmed:author | pubmed-author:FannW EWE | lld:pubmed |
| pubmed-article:8094629 | pubmed:author | pubmed-author:HamiltonJ DJD | lld:pubmed |
| pubmed-article:8094629 | pubmed:author | pubmed-author:GrandchampBB | lld:pubmed |
| pubmed-article:8094629 | pubmed:author | pubmed-author:ChakrabortyRR | lld:pubmed |
| pubmed-article:8094629 | pubmed:author | pubmed-author:PatelP IPI | lld:pubmed |
| pubmed-article:8094629 | pubmed:author | pubmed-author:SandersA RAR | lld:pubmed |
| pubmed-article:8094629 | pubmed:author | pubmed-author:Rincon-LimasD... | lld:pubmed |
| pubmed-article:8094629 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8094629 | pubmed:volume | 8 | lld:pubmed |
| pubmed-article:8094629 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8094629 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8094629 | pubmed:pagination | 211-21 | lld:pubmed |
| pubmed-article:8094629 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:8094629 | pubmed:meshHeading | pubmed-meshheading:8094629-... | lld:pubmed |
| pubmed-article:8094629 | pubmed:meshHeading | pubmed-meshheading:8094629-... | lld:pubmed |
| pubmed-article:8094629 | pubmed:meshHeading | pubmed-meshheading:8094629-... | lld:pubmed |
| pubmed-article:8094629 | pubmed:meshHeading | pubmed-meshheading:8094629-... | lld:pubmed |
| pubmed-article:8094629 | pubmed:meshHeading | pubmed-meshheading:8094629-... | lld:pubmed |
| pubmed-article:8094629 | pubmed:meshHeading | pubmed-meshheading:8094629-... | lld:pubmed |
| pubmed-article:8094629 | pubmed:meshHeading | pubmed-meshheading:8094629-... | lld:pubmed |
| pubmed-article:8094629 | pubmed:meshHeading | pubmed-meshheading:8094629-... | lld:pubmed |
| pubmed-article:8094629 | pubmed:meshHeading | pubmed-meshheading:8094629-... | lld:pubmed |
| pubmed-article:8094629 | pubmed:meshHeading | pubmed-meshheading:8094629-... | lld:pubmed |
| pubmed-article:8094629 | pubmed:meshHeading | pubmed-meshheading:8094629-... | lld:pubmed |
| pubmed-article:8094629 | pubmed:meshHeading | pubmed-meshheading:8094629-... | lld:pubmed |
| pubmed-article:8094629 | pubmed:meshHeading | pubmed-meshheading:8094629-... | lld:pubmed |
| pubmed-article:8094629 | pubmed:meshHeading | pubmed-meshheading:8094629-... | lld:pubmed |
| pubmed-article:8094629 | pubmed:meshHeading | pubmed-meshheading:8094629-... | lld:pubmed |
| pubmed-article:8094629 | pubmed:meshHeading | pubmed-meshheading:8094629-... | lld:pubmed |
| pubmed-article:8094629 | pubmed:meshHeading | pubmed-meshheading:8094629-... | lld:pubmed |
| pubmed-article:8094629 | pubmed:meshHeading | pubmed-meshheading:8094629-... | lld:pubmed |
| pubmed-article:8094629 | pubmed:meshHeading | pubmed-meshheading:8094629-... | lld:pubmed |
| pubmed-article:8094629 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8094629 | pubmed:articleTitle | Association between genetic variation at the porphobilinogen deaminase gene and schizophrenia. | lld:pubmed |
| pubmed-article:8094629 | pubmed:affiliation | Institute for Molecular Genetics, Baylor College of Medicine, Houston, TX 77030. | lld:pubmed |
| pubmed-article:8094629 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8094629 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
